These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33920475)

  • 1. Pharmacokinetics and Pharmacodynamics of a Depolymerized Glycosaminoglycan from
    Liu S; Zhang T; Sun H; Lin L; Gao N; Wang W; Li S; Zhao J
    Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33920475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and pharmacokinetics/pharmacodynamics of the anticoagulant tetradecasaccharide oHG-14 as an intrinsic tenase inhibitor.
    Zhang T; Lin L; Ren L; Sun H; Wang W; Liu S; Li S; Xiao C; Gao N; Zhao J
    Thromb Res; 2024 Aug; 240():109041. PubMed ID: 38824798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.
    Zhou L; Gao N; Sun H; Xiao C; Yang L; Lin L; Yin R; Li Z; Zhang H; Ji X; Zhao J
    Thromb Haemost; 2020 Apr; 120(4):607-619. PubMed ID: 32289860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The components and activities analysis of a novel anticoagulant candidate dHG-5.
    Sun H; Gao N; Ren L; Liu S; Lin L; Zheng W; Zhou L; Yin R; Zhao J
    Eur J Med Chem; 2020 Dec; 207():112796. PubMed ID: 32942073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Assessment of APTT Reagents for Evaluating Anticoagulant Sensitivity of Fucosylated Glycosaminoglycans (FGs) Derived from Sea Cucumbers.
    Sun H; Yang S; Li P; Shang X; Wang P; Zhang J; Yuan L; Yin R; Gao N; Zhao J
    Mar Drugs; 2023 Oct; 21(11):. PubMed ID: 37999392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka.
    Suzuki N; Kitazato K; Takamatsu J; Saito H
    Thromb Haemost; 1991 Apr; 65(4):369-73. PubMed ID: 1647552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model.
    Minamiguchi K; Kitazato KT; Nagase H; Sasaki E; Ohwada K; Kitazato K
    Kidney Int; 2003 Apr; 63(4):1548-55. PubMed ID: 12631372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and anticoagulant analysis of the novel branched fucosylated glycosaminoglycan from sea cucumber Holothuria nobilis.
    Li S; Zhong W; Pan Y; Lin L; Cai Y; Mao H; Zhang T; Li S; Chen R; Zhou L; Wang W; Cui Q; Yin R; Huang S; Zhao J
    Carbohydr Polym; 2021 Oct; 269():118290. PubMed ID: 34294316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs.
    Minamiguchi K; Kitazato KT; Sasaki E; Nagase H; Kitazato K
    Thromb Haemost; 1997 Jun; 77(6):1148-53. PubMed ID: 9241748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
    Sasaki E; Minamiguchi K; Kitazato KT; Nagase H; Kitazato K
    Haemostasis; 1997; 27(4):174-83. PubMed ID: 9483172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR characterization and anticoagulant activity of the oligosaccharides from the fucosylated glycosaminoglycan isolated from Holothuria coluber.
    Yang W; Chen D; He Z; Zhou L; Cai Y; Mao H; Gao N; Zuo Z; Yin R; Zhao J
    Carbohydr Polym; 2020 Apr; 233():115844. PubMed ID: 32059896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of a depolymerized holothurian glycosaminoglycan in plasma after intravenous administration by postcolumn HPLC.
    Huang Y; Toyoda H; Koshiishi I; Toida T; Imanari T
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2182-6. PubMed ID: 8582021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral absorption and clearance of partially depolymerized fucosyl chondroitin sulfate from sea cucumber.
    Imanari T; Washio Y; Huang Y; Toyoda H; Suzuki A; Toida T
    Thromb Res; 1999 Feb; 93(3):129-35. PubMed ID: 10030829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
    Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
    Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHG, a new depolymerized holothurian glycosaminoglycan, exerts an antithrombotic effect with less bleeding than unfractionated or low molecular weight heparin, in rats.
    Kitazato K; Kitazato KT; Nagase H; Minamiguchi K
    Thromb Res; 1996 Oct; 84(2):111-20. PubMed ID: 8897700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depolymerized holothurian glycosaminoglycan (DHG) prevents neointimal formation in balloon-injured rat carotid artery.
    Igarashi M; Takeda Y; Mori S; Takahashi K; Fuse T; Yamamura M; Saito Y
    Atherosclerosis; 1997 Feb; 129(1):27-31. PubMed ID: 9069513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Toxicology of Native Fucosylated Glycosaminoglycans and the Safety of Their Depolymerized Products as Anticoagulants.
    Lin L; Li S; Gao N; Wang W; Zhang T; Yang L; Yang X; Luo D; Ji X; Zhao J
    Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
    Nagase H; Kitazato KT; Sasaki E; Hattori M; Kitazato K; Saito H
    Thromb Haemost; 1997 Feb; 77(2):399-402. PubMed ID: 9157603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
    Kreutz R; Persson PB; Kubitza D; Thelen K; Heitmeier S; Schwers S; Becka M; Hemmrich M
    J Thromb Haemost; 2017 Oct; 15(10):2017-2028. PubMed ID: 28805299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.